OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
13
Results
Show all
Save search
Copy query
Show results for
Unknown
(13)
Publication Date
Release Date
2025
(3)
2024
(2)
2023
(1)
2022
(1)
2021
(1)
2020
(1)
2019
(1)
2017
(1)
2013
(1)
2010
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Vitamin D receptor agonists target CXCL10: new therapeutic tools for resolution of inflammation.
Not available
S-EPMC3652186
|
biostudies-literature
Cite
The p75
NTR
-mediated effect of nerve growth factor in L6C5 myogenic cells.
Not available
S-EPMC5716223
|
biostudies-literature
Cite
Systemic Response of Antioxidants, Heat Shock Proteins, and Inflammatory Biomarkers to Short-Lasting Exercise Training in Healthy Male Subjects.
Not available
S-EPMC8629640
|
biostudies-literature
Cite
ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis.
Not available
S-EPMC11233331
|
biostudies-literature
Cite
The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species.
Not available
S-EPMC7555932
|
biostudies-literature
Cite
1
H-NMR metabolomics reveals the Glabrescione B exacerbation of glycolytic metabolism beside the cell growth inhibitory effect in glioma.
Not available
S-EPMC6712882
|
biostudies-literature
Cite
Vitamin D Supplementation and Testosterone Levels in Breast Cancer Survivors.
Not available
S-EPMC12564732
|
biostudies-literature
Cite
Plasma-derived extracellular vesicles released after endurance exercise exert cardioprotective activity through the activation of antioxidant pathways.
Not available
S-EPMC10220283
|
biostudies-literature
Cite
A Comprehensive <i>In Vitro</i> Characterization of a New Class of Indole-Based Compounds Developed as Selective Haspin Inhibitors.
Not available
S-EPMC11320660
|
biostudies-literature
Cite
Tumour-infiltrating leucocytes as prognostic biomarkers of bevacizumab-treated ovarian cancer patients results from the phase IV MITO16A/MaNGO OV-2 clinical trial.
Not available
S-EPMC12623770
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets